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Objective: To investigate the ethanolic extract and its fractions of Hyptis suaveolens
(H. suaveolens) for antinociceptive and central nervous system depressant effects.
Methods: Dried and coarsely powdered aerial parts of plant material were extracted in
80% aqueous ethanol. Further extract was fractionated using solvents of varying polarity.
Analgesic properties was assessed using acetic acid-induced writhing and hot plate test
and locomotor activity were performed in mice using hole board test.
Results: The petroleum ether and ethyl acetate extracts had produced signiﬁcant anal-
gesic properties and were found to be maximum when tested at 400 mg/kg. Both extracts
signiﬁcantly increased the latency time in hot plate test and the action was antagonised by
naloxone. The naloxone was not able to alter H. suaveolens induced antinociceptive
effect in writhing test.
Conclusions: From the point of central nervous system depressant and good protective
effect on chemical and thermal pain stimuli, it indicates that H. suaveolens might have
resulted from activation of opioid and/or peripheral receptors.1. Introduction
Natural products derived from plants are important to cure
various disease conditions. Side effects of various allopathic
drugs and development of resistance to currently used drugs
increased the emphasis on the use of plant materials as a source
of medicine for a wide variety of human ailments. Incidentally,
plants and herbs are persistently being studied for the discovery
of novel therapeutic agents. India is one of the biodiversity
centres with the presence of about 20000 plants having a good
medicinal value and used by different traditional communities[1–
3]. Traditionally, plants passed empirical testing against speciﬁc
diseases and demonstrated that they are well tolerated in
humans. However, many of these traditionally used medicinal
plants were not investigated scientiﬁcally with regard to the
modern medicine. Since the use of herbal drugs remains a
good alternative to allopathic agents, it is important to conductscientiﬁc evaluation of as many traditionally used plants as
possible with reference to the modern system of medicine[4,5].
Hyptis suaveolens (L.) Poit. (H. suaveolens) (Lamiaceae) is a
fast growing perennial herb found in dense clumps along road side
and distributed in the tropical and sub-tropical region. It is used
traditionally for the treatment of respiratory tract infections, cold,
pain, inﬂammation, fever, skin diseases and diabetes[6,7]. The leaves
of it are reported to be rich in essential oils and useful in antifungal,
antibacterial and anticonvulsant activities[8–11]. The aerial parts are
reported to contain antiplasmodial diterpenoids and triterpenoid
heptadienic acid[12,13]. The leaves are also reported to possess
antihyperglycemic activity in the management of diabetes
mellitus[14]. Phytochemically, its leaves are reported to contain
hentriacontane, hentriacontanone, lupeol, acetate and friedelin[15].
In view of the reported analgesic properties of H. suaveolens,
the present study is conducted to evaluate antinociceptive effects
of H. suaveolens and the action mechanism on several experi-
mental models in mice. The activity of central nervous system
(CNS) is also investigated in order to examine antinociceptive
activity related to central depression action.
2. Materials and methods
2.1. Preparation of plant material and authentiﬁcation
The aerial parts of H. suaveolens were collected from
Rajendra Nagar, Hyderabad. The plant was identiﬁed andarticle under the CC BY-NC-ND license (http://
Azmathunnisa Begum et al./Journal of Acute Disease 2016; 5(5): 397–401398authenticated by Dr. P.V. Prasanna, scientist and taxonomist of
Botanical Survey of India, Hyderabad, India. A voucher spec-
imen of H. suaveolens (AUB-HSL-2013) was maintained in the
Department of Phytochemistry and Pharmacognosy of G. Pulla
Reddy College of Pharmacy, Hyderabad, India. The aerial parts
were cut, air dried and ground into powder.
2.2. Preparation of plant extract and its fractions
Dried powder material of H. suaveolens was extracted with
80% aqueous ethyl alcohol by maceration for 5 days. The per-
centage yield of crude ethanolic extractwas 9.23. The concentrated
aqueous ethanolic extract was suspended in 500 mL of distilled
water and fractionated with petroleum ether (4 × 500 mL), chlo-
roform (4 × 500 mL), ethyl acetate (4 × 500 mL) and n-butyl
alcohol (4 × 500 mL). The percentage yields of petroleum ether,
chloroform, ethyl acetate, n-butanol and left over aqueous fractions
ofH. suaveolenswere 0.56, 0.59, 0.2, 0.55 and 0.574 respectively.
2.3. Chemicals
All the chemicals, reagents, solvents used were of analytical
grade. Aspirin, morphine, diazepam and naloxone were pur-
chased locally.
2.4. Animals
All experimental procedures involving animals were conducted
in accordance to guidelines of Committee for the Purpose of Con-
trol and Supervision of Experiments on Animals and all the pro-
cedures for investigating experimental pain in conscious animals in
the study was approved by Institutional Animals Ethics Committee
of G. Pulla Reddy College of Pharmacy, Hyderabad, India[16].
Male Swiss albino mice (25–30 g) were used in the present
study. The animals were housed in standard laboratory condi-
tions of temperature (21 ± 2) C, relative humidity, 12 h dark
and 12 h light cycles and had free access to feed and water ad
libitum during the quarantine period. Besides, the animals were
fasted for 6 h before experimentation, but had free access to
water. All the extracts and drugs were administered orally as a
ﬁne suspension of 0.5% carboxy methyl cellulose (CMC).
2.5. Antinociceptive activity
2.5.1. Acetic acid-induced writhing test
The acetic acid-induced writhing test was carried out in pre-
screened mice[17,18]. The animals were divided into 15 groups of
six animals each. Group 1 served as control and received vehicle
CMC. Groups 2–11 received aqueous ethanolic extract,
petroleum ether, chloroform, ethyl acetate and butanol fractions
at an oral dose of 200 and 400 mg/kg of each extract. Group 12
served as positive control and received acetyl salicylic acid at an
oral dose of 100 mg/kg. In an attempt to investigate the
participation of opioid system in antinociceptive effects of
H. suaveolens, a separate group of mice was pretreated with non-
selective receptor antagonist, naloxone (5 mg/kg), which was
injected 15 min before the administration of petroleum ether and
ethyl acetate fractions (400mg/kg,p.o.) forGroups 13 and 14.After
30min of extract/drug administration, all the animals were given an
i.p. injection of 0.6% acetic acid (volume of injection was 0.1 mL/
10 g) and writhes produced were recorded for 30 min. Group 15
animals received naloxone (5 mg/kg) and aspirin (100 mg/kg).2.5.2. Hot plate test
The temperature of Eddy's hot plate was maintained at
(55.0 ± 0.2) C. The basal reaction time of all the animals towards
thermal heat was recorded. The animals which showed paw lick-
ings or jumping responses within 5 s were selected for the study[19].
The pre-screened animals were divided into 15 groups of 10 ani-
mals each. Control animals were treated with CMC (Group 1).
Groups 2–11 received aqueous ethanolic extract, petroleum ether,
chloroform, ethyl acetate and butanol extracts at an oral test doses
of 200 and 400 mg/kg. Group 11 served as positive control and
treated with morphine (5 mg/kg, p.o.). The opioid receptor
antagonist naloxone (5 mg/kg) was also tested along with petro-
leum ether and ethyl acetate extracts (400 mg/kg, p.o., Groups 13
and 14) and morphine (5 mg/kg, p.o., Group 15). All the sub-
stances were administered for 30 min before the beginning of the
experiment. The latency time was measured before and at 30, 60,
120 and 180min after the administration of the extract. The latency
period of 20 s was deﬁned as a cut-off mark and measurement was
terminated if the latency exceeded the period to avoid injury.
2.5.3. CNS depressant activity
The activity of H. suaveolens on CNS was evaluated by per-
forming assays of its effect on exploratory capacity (hole board
test) and locomotory activity. In each experiment, the mice were
divided into 13 groups consisting of six animals in each group.
The animals of Group 1 were treated with vehicle and served as
control. Aqueous ethanol, petroleum ether, chloroform, ethyl
acetate and butanol extracts were administered to Groups 2–11
animals at an oral dose of 200 and 400 mg/kg as a ﬁne CMC
suspension. Groups 12 and 13 served as positive control and
orally received diazepam (2 mg/kg) and morphine (10 mg/kg).
2.5.3.1. Hole board test
Hole board test described by Sonavane et al. was employed[20].
The animals were placed on a board (40 cm × 40 cm) with 16 holes
symmetrically distributed in 4 rows. After ﬁnishing the oral
administration of test and standard substance at 30 min, each
animal was placed carefully in the centre of board and number of
head pokes (head was dipped into the hole) for 5 min and recorded.
2.5.3.2. Locomotory activity
The locomotory activity was measured by actophotometer
(INCOPhotoactometer,Ambala, India).Acountwas recordedwhen
the beam of light falling on the photocell of the actophotometer was
cut off by animals. The basal activity score was obtained by placing
each animal individually in actophotometer for 10 min. After
administration for 30 min, each animal was placed carefully in the
centre of actophotometer for recording the activity score[21,22].
2.6. Statistical analysis
All the values were expressed as mean ± SEM and analysed
statistically by ANOVA followed by Dunnett's multiple compari-
son test. Values of P < 0.05 were considered to be signiﬁcant[23].
3. Results
3.1. Effect of H. suaveolens on acetic acid-induced
writhing test
The inhibitory effects of ethanolic extract of H. suaveolens
and its fractions in writhing test were shown in Table 1.
Table 1
Effect ofH. suaveolens on acetic acid-induced abdominal writhing in mice.
Groups Treatment Writhings Inhibition (%)
1 Control 75.83 ± 0.47 –
2 Aqueous ethanol extract
(400 mg/kg)
51.75 ± 0.89* 31.75
3 Aqueous ethanol extract
(200 mg/kg)
55.50 ± 0.47* 26.80
4 Petroleum ether extract
(400 mg/kg)
39.33 ± 0.66* 48.13
5 Petroleum ether extract
(200 mg/kg)
61.00 ± 0.93* 19.55
6 Chloroform extract
(400 mg/kg)
62.33 ± 0.61* 17.80
7 Chloroform extract
(200 mg/kg)
71.00 ± 0.57* 6.36
8 Ethyl acetate extract
(400 mg/kg)
44.66 ± 0.55* 41.10
9 Ethyl acetate extract
(200 mg/kg)
62.66 ± 0.71* 13.17
10 Butanol extract
(400 mg/kg)
70.33 ± 0.66* 7.25
11 Butanol extract
(200 mg/kg)
71.66 ± 0.49* 5.49
12 Aspirin (100 mg/kg) 19.83 ± 0.60* 73.84
13 Petroleum ether + naloxone
extract (400 mg/kg + 5
mg/kg)
40.83 ± 0.30* 46.15
14 Ethyl acetate + naloxone
extract (400 mg/kg + 5
mg/kg)
46.10 ± 0.67* 39.20
15 Aspirin + naloxone
(100 mg/kg + 5 mg/kg)
22.00 ± 0.57* 70.98
All values were expressed as mean ± SEM, n = 6; *: P < 0.01 compared
with control.
Table 2






1 Control 2.10 ± 0.17 2.20 ± 0.13 2
2 AEHS (400 mg/kg) 2.10 ± 0.23 3.00 ± 0.33 4
3 AEHS (200 mg/kg) 2.30 ± 0.26 2.50 ± 0.34* 2
4 PEHS (400 mg/kg) 2.30 ± 0.21 2.70 ± 0.26 6
5 PEHS (200 mg/kg) 2.20 ± 0.20 2.50 ± 0.16* 2
6 CHS (400 mg/kg) 2.00 ± 0.21 2.00 ± 0.25 2
7 CHS (200 mg/kg) 2.70 ± 0.15 2.70 ± 0.21 2
8 EAHS (400 mg/kg) 2.00 ± 0.14 2.30 ± 0.15 3
9 EAHS (200 mg/kg) 2.50 ± 0.37 2.60 ± 0.23* 2
10 BHS (400 mg/kg) 2.20 ± 0.20 2.30 ± 0.33 2
11 BHS (200 mg/kg) 2.70 ± 0.33 2.70 ± 0.47* 2
12 Morphine (5 mg/kg) 2.70 ± 0.30 11.10 ± 0.43** 1
13 PEHS + naloxone
(400 mg/kg + 5 mg/kg)
2.40 ± 0.26 2.40 ± 0.33* 2
14 LAHS + naloxone
(400 mg/kg + 5 mg/kg)
2.30 ± 0.33 2.40 ± 0.33 2
15 Morphine + naloxone
(5 mg/kg + 5 mg/kg)
2.10 ± 0.31 5.50 ± 0.50** 5
AEHS: Aqueous ethanolic extract of H. suaveolens; PEHS: Petroleum ethe
EAHS: Ethyl acetate extract of H. suaveolens; BHS: Butanol extract of H. sua
**: P < 0.01 compared with control. All values were expressed as mean ± S
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(P < 0.01) inhibited the writhings in mice at both test dose
levels. The maximum activity was observed in the animals
receiving a test dose of 400 mg/kg. Among all extracts, pe-
troleum ether extracts and ethyl acetate extracts had produced
the maximum inhibitory effect with 48.13% and 41.0% pro-
tection when tested at 400 mg/kg. The administration of
naloxone (5 mg/kg) along with petroleum ether, ethyl acetate
extracts and aspirin demonstrated signiﬁcant (P < 0.01)
analgesic effects with percentage inhibition of 46.15, 39.20
and 70.98. None of the inhibitory effects of extracts were
comparable with aspirin activity. These results indicated that
naloxone had no effect on antinociceptive activity of
H. suaveolens and aspirin.
3.2. Effect of H. suaveolens on the hot plate test
The results presented in Table 2 and showed the time course
of antinociception produced by various extracts of
H. suaveolens. Oral administration of all the extracts resulted in
signiﬁcant prolongation of latency time in hot plate test.
Among all the extracts, petroleum ether and ethyl acetate ex-
tracts had produced higher latency time at 120 and 90 min
respectively. The course of analgesic action was initiated from
the 60 min of experiment. The animals received 400 mg/kg test
dose had produced maximum antinociceptive properties.
Chloroform and butanol extract were not able to produce any
signiﬁcant analgesic property. At 90 min, the mean latency
time of petroleum ether and ethyl acetate extracts were









.00 ± 0.14 2.10 ± 0.17 2.20 ± 0.20 2.00 ± 0.14
.60 ± 0.33** 5.30 ± 0.21** 5.30 ± 0.36** 3.20 ± 0.41
.80 ± 0.24* 3.20 ± 0.35* 2.80 ± 0.32* 2.30 ± 0.21*
.20 ± 0.32** 9.90 ± 0.50** 8.90 ± 0.37** 4.10 ± 0.31**
.70 ± 0.21* 3.20 ± 0.20* 2.90 ± 0.17* 2.40 ± 0.16*
.50 ± 0.16 3.00 ± 0.25 3.20 ± 0.24 2.60 ± 0.26
.70 ± 0.26** 2.90 ± 0.23** 2.80 ± 0.24** 2.60 ± 0.22
.70 ± 0.30** 6.40 ± 0.40** 5.90 ± 0.48** 3.50 ± 0.40*
.90 ± 0.31* 3.20 ± 0.20* 2.80 ± 0.20* 2.80 ± 0.46*
.30 ± 0.36 3.10 ± 0.31 2.80 ± 0.51 2.40 ± 0.47
.80 ± 0.44* 2.90 ± 0.27* 2.90 ± 0.40* 2.70 ± 0.47*
3.0 ± 0.49** 17.30 ± 0.55** 16.90 ± 0.64** 14.60 ± 0.40**
.50 ± 0.26* 3.20 ± 0.44* 3.10 ± 0.34* 2.30 ± 0.21*
.40 ± 0.26 2.60 ± 0.30 2.50 ± 0.30 2.30 ± 0.39
.70 ± 0.51** 6.40 ± 0.33** 6.20 ± 0.46** 4.00 ± 0.39*
r extract of H. suaveolens; CHS: Chloroform extract of H. suaveolens;
veolens; LAHS: Left over aqueous extract of H. suaveolens; *: P < 0.05;
EM, n = 10.
Azmathunnisa Begum et al./Journal of Acute Disease 2016; 5(5): 397–401400(2.10 ± 0.17) s and (17.30 ± 0.55) s for control and morphine
treated groups respectively. The analgesic effects of both ex-
tracts were not comparable with morphine activity during any
course of time. Administration of naloxone (5 mg/kg) had
reversed the analgesic properties induced by petroleum ether
and ethyl acetate extracts. Similarly, the effect produced by
morphine (5 mg/kg) was signiﬁcantly blocked by administra-
tion of naloxone.
3.3. Hole board test
The results of hole board test was presented in Table 3. All
the extracts had produced a signiﬁcant dose dependent activity.Table 3
Effect of H. suaveolens extracts on hole board test in mice.
Groups Treatment Head pokes/dips
1 min 2 min 3 min 4 min 5 min
1 Control 14.16 ± 0.47 15.33 ± 0.49 14.50 ± 0.42 14.50 ± 0.84 13.00 ± 0.36
2 AEHS (400 mg/kg, p.o.) 5.00 ± 0.36** 4.16 ± 0.47** 4.00 ± 0.36** 3.83 ± 0.54** 2.83 ± 0.47**
3 AEHS (200 mg/kg, p.o.) 11.83 ± 0.74 12.50 ± 0.61 12.66 ± 0.49 11.50 ± 0.61* 11.33 ± 0.33*
4 PEHS (400 mg/kg, p.o.) 9.33 ± 0.49** 8.66 ± 0.49** 7.83 ± 0.60** 4.16 ± 0.60** 3.50 ± 0.42**
5 PEHS (200 mg/kg, p.o.) 12.16 ± 0.74 11.50 ± 0.76* 10.16 ± 0.60** 11.00 ± 0.63** 10.66 ± 0.55**
6 CHS (400 mg/kg, p.o.) 5.83 ± 0.60** 6.00 ± 0.57** 5.66 ± 0.49** 5.33 ± 0.33** 5.00 ± 0.36**
7 CHS (200 mg/kg, p.o.) 15.00 ± 0.73 14.16 ± 0.70 14.00 ± 0.96 13.83 ± 0.87 14.66 ± 0.80
8 EAHS (400 mg/kg, p.o.) 6.00 ± 0.73** 5.66 ± 0.66** 5.16 ± 0.79** 4.83 ± 0.60** 3.83 ± 0.47**
9 EAHS (200 mg/kg, p.o.) 10.83 ± 0.74** 10.33 ± 0.49** 11.00 ± 0.77** 10.50 ± 0.42** 9.83 ± 0.60**
10 BHS (400 mg/kg, p.o.) 6.83 ± 0.87** 7.33 ± 0.80** 6.83 ± 0.60** 7.33 ± 0.42** 7.83 ± 0.70**
11 BHS (200 mg/kg, p.o.) 13.66 ± 0.55 13.50 ± 0.95 14.50 ± 0.56 14.16 ± 0.60 14.33 ± 0.76
12 Diazepam (2 mg/kg, p.o.) 5.66 ± 0.66** 5.33 ± 0.55** 5.33 ± 0.61** 4.66 ± 0.55** 4.50 ± 0.56**
13 Morphine (10 mg/kg, p.o.) 6.33 ± 0.66** 4.66 ± 0.42** 4.50 ± 0.47** 3.83 ± 0.47** 3.33 ± 0.49**
AEHS: Aqueous ethanolic extract of H. suaveolens; PEHS: Petroleum ether fraction of H. suaveolens; CHS: Chloroform fraction of H. suaveolens;
EAHS: Ethyl acetate fraction of H. suaveolens; BHS: Butanol fraction of H. suaveolens; *: P < 0.05 compared with control; **: P < 0.01 compared
with control. All values were expressed as mean ± SEM, n = 6.
Table 4
Effect of H. suaveolens on locomotor activity.
Groups Treatment Locomotor activity score in 10 min Reduction in activity (%)
Before treatment After treatment
1 Control 402.50 ± 0.76 396.00 ± 0.73 –
2 AEHS (400 mg/kg) 217.33 ± 0.66 87.16 ± 0.79** 59.89
3 AEHS (200 mg/kg) 242.50 ± 0.76 212.16 ± 0.60** 12.50
4 PEHS (400 mg/kg) 251.66 ± 0.94 90.16 ± 0.47** 64.17
5 PEHS (200 mg/kg) 192.33 ± 0.76 142.00 ± 0.57** 26.16
6 CHS (400 mg/kg) 200.50 ± 0.76 182.66 ± 0.84** 8.89
7 CHS (200 mg/kg) 262.16 ± 0.60 252.66 ± 0.49* 3.62
8 EAHS (400 mg/kg) 224.50 ± 0.76 136.33 ± 0.66** 39.27
9 EAHS (200 mg/kg) 317.50 ± 0.56 292.16 ± 0.60** 7.98
10 BHS (400 mg/kg) 307.50 ± 0.92 275.83 ± 0.60** 10.29
11 BHS (200 mg/kg) 331.66 ± 0.47 326.83 ± 0.60* 1.45
12 Diazepam (2 mg/kg) 217.50 ± 0.76 57.83 ± 0.60** 69.48
13 Morphine (10 mg/kg) 234.83 ± 0.47 71.66 ± 0.55** 73.41
AEHS: Aqueous ethanolic extract of H. suaveolens; PEHS: Petroleum ether extract of H. suaveolens; CHS: Chloroform extract of H. suaveolens;
EAHS: Ethyl acetate extract of H. suaveolens; BHS: Butanol extract of H. suaveolens; **: P < 0.01 compared with control.The head dip responses were signiﬁcantly reduced in animals
treated with a dose of 400 mg/kg. Among all the extracts,
aqueous ethanolic extract, ethyl acetate extract followed by
petroleum ether extracts had produced maximum activity when
compared to control. The action produced by aqueous etha-
nolic extract (400 mg/kg) was signiﬁcantly high when
compared to diazepam and morphine during the entire course
of experiment.3.4. Locomotory activity
Table 4 represented the results of H. suaveolens locomotor
activity. Among all the extracts, petroleum ether and aqueous
ethanolic (400 mg/kg) extracts had produced signiﬁcant
(P < 0.01) reduction in locomotor activity with percentage
reduction of 64.17 and 59.89 respectively. Between the two test
dose levels, animals received 400 mg/kg had produced
maximum activity. Butanolic and chloroform extracts did not
produced any action compared with control. The effect of
diazepam and morphine was more marked with 69.48% and
73.41% reduction in activity and the action was comparable with
animals treated with petroleum ether extract (400 mg/kg).4. Discussion
The results of the present study indicate that oral administration
of H. suaveolens extracts has produced signiﬁcant analgesic
properties (except butanolic extract) at 400 mg/kg. The petroleum
ether and ethyl acetate extracts of H. suaveolens have produced
high signiﬁcant central analgesic (hot plate test) and protective
effect on chemical (acetic acid injection) stimuli at 400 mg/kg.
Azmathunnisa Begum et al./Journal of Acute Disease 2016; 5(5): 397–401 401Such an efﬁcacy on these two stimuli is the characteristic of central
analgesics like morphine, while peripheral analgesic (acetyl sali-
cylic acid) is known to be inactive on thermal pain stimuli.
The petroleum ether and ethyl acetate extracts signiﬁcantly
inhibited the acetic acid-induced writhing in mice with percentage
protection of 48.13 and 21.39 respectively, followed by aqueous
ethanolic extract producing percentage protection of 31.97. This
test was widely used for the evaluation of analgesics and involved
the release of prostaglandins and phlogistic mediators like prosta-
glandin E2 and prostaglandin E2a and these levelswere increased in
peritoneal ﬂuid of the acetic acid-induced mice. It was postulated
that acetic acid acts indirectly by inducing the release of endoge-
nous mediators which stimulates the nociceptive neurons that are
sensitive to non-steroidal anti-inﬂammatory drugs and narcotics[24].
The hot plate test employed to verify the H. suaveolens extracts
could show central antinociceptive drugs[25]. Among all the
extracts, petroleum ether and ethyl acetate extracts had
signiﬁcantly increased in the latency time in hot plate test at dose
of 400 mg/kg. Apparently, the effect largely depends on
endogenous opioids. Although hot plate test is commonly used
for the assay of narcotic analgesics, other drugs such as sedatives,
muscle relaxants and psychometric drugs act centrally[19].
To determine the possible mechanism of action of petro-
leum ether and ethyl acetate extracts of H. suaveolens to
produce analgesia, naloxone was used as a selective antago-
nist of opioid receptors. Naloxone apparently acts by antag-
onising the action of endogenous opioid involved in pain
and stress[26]. The results indicated that naloxone markedly
reversed the antinociceptive effect of petroleum ether and
ethyl acetate extracts (400 mg/kg) and morphine (10 mg/kg)
in heat induced pain (hot plate). The effect of petroleum
ether and ethyl acetate extracts in acetic acid-induced pain
model was unaffected by naloxone or the analgesic effects
were not antagonised.
The results of antinociceptive study led us to carry out further
investigation of H. suaveolens on CNS hole board test and loco-
motor activity in mice. The aqueous ethanol, petroleum ether and
ethyl acetate extracts produced signiﬁcant dose dependent activity
onCNS. Themechanism underlined that this effect was unknown.
However, from the point of CNS depressant and good protective
effect on chemical and thermal stimuli, it indicated that
H. suaveolens may have morphinomimetic properties. However,
naloxone is not able to alter the H. suaveolens induced anti-
nociceptive effect on writhing test. Thus, the observed anti-
nociceptive activity ofH. suaveolensmight have resulted from the
activation of peripheral and/or opioid receptors. The results of
present investigation conﬁrm the antinociceptive properties of
H. suaveolens and the reports of traditional practices were stands
to be correct. However, the exact mechanism of action is still not
known at this stage and has to be established in various models.
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